Besides the generation of disease models from patient derived cells, new gene editing technologies find application: de la Roche et al. generated a model for the Brugada syndrome carrying the A735V mutation in the SCN5A gene introduced by CRISPR/Cas9 in order to be independent of the patient’s genetic background. Here, SCN5A is linked to Brugada syndrome.